Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 246 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-TADALAFIL | 20MG | TABLET | Resolved | 2021-07-16 | 2021-08-16 | 142690 |
APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Resolved | 2021-07-23 | 2021-09-14 | 142967 |
APO-AMLODIPINE | 10MG | TABLET | Resolved | 2021-07-23 | 2021-08-23 | 142970 |
APO-INDAPAMIDE 1.25 MG TABLETS | 1.25MG | TABLET | Resolved | 2021-07-23 | 2021-08-31 | 142979 |
APO-SIMVASTATIN | 20MG | TABLET | Resolved | 2021-07-23 | 2022-03-01 | 142985 |
APO-LORAZEPAM | 2MG | TABLET | Resolved | 2021-08-03 | 2021-09-07 | 143401 |
APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2021-08-03 | 2021-08-16 | 143404 |
APO-NALTREXONE | 50MG | TABLET | Resolved | 2021-08-13 | 2021-08-31 | 144142 |
APO-PRAVASTATIN | 10MG | TABLET | Resolved | 2021-08-16 | 2021-09-27 | 144186 |
APO-PRAVASTATIN | 20MG | TABLET | Resolved | 2021-08-16 | 2021-10-05 | 144189 |
APO-AMITRIPTYLINE | 25MG | TABLET | Resolved | 2021-08-16 | 2022-05-13 | 144195 |
APO-AMLODIPINE | 5MG | TABLET | Resolved | 2021-08-16 | 2021-09-07 | 144198 |
APO-CEPHALEX | 500MG | TABLET | Resolved | 2021-08-16 | 2021-10-12 | 144201 |
APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2021-08-16 | 2021-10-05 | 144204 |
APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2021-08-16 | 2021-09-07 | 144209 |
APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Resolved | 2021-08-27 | 2021-11-19 | 144656 |
APO-LEVETIRACETAM | 500MG | TABLET | Resolved | 2021-08-27 | 2021-10-01 | 144659 |
APO-MEDROXY | 100MG | TABLET | Resolved | 2021-08-27 | 2022-01-31 | 144662 |
APO-TADALAFIL | 10MG | TABLET | Resolved | 2021-08-27 | 2021-09-14 | 144669 |
APO-ENALAPRIL | 20MG | TABLET | Resolved | 2021-08-27 | 2022-07-11 | 144672 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ASA LD | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60252 |
APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
COATED DAILY LOW DOSE ASA 81 MG | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-04 | 71083 |
BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-03 | 71090 |
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-07 | 2019-08-08 | 60420 |
APO-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-07 | 2018-09-15 | 60438 |
APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-08 | 2018-10-05 | 60717 |
APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-08-07 | 2019-08-07 | 91117 |
APO-DICLO SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4909 |
APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4915 |
APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-01-04 | 2019-01-04 | 71207 |
APO-NEVIRAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-03-11 | 2019-03-11 | 78257 |
APO-ZOLMITRIPTAN RAPID | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-09-08 | 2018-09-15 | 60867 |